Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LEXXW

Lexaria Bioscience (LEXXW)

Lexaria Bioscience Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LEXXW
DateTimeSourceHeadlineSymbolCompany
06/12/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LEXXWLexaria Bioscience Corporation
06/11/20245:00PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LEXXWLexaria Bioscience Corporation
06/03/20241:05PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:LEXXWLexaria Bioscience Corporation
05/15/20245:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
05/10/20245:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
05/10/20245:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
05/10/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
05/10/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LEXXWLexaria Bioscience Corporation
07/22/20218:18AMInvestorsHub NewsWireLexaria Summarizes Successful Antiviral Drug Studies and Ongoing StrategyNASDAQ:LEXXWLexaria Bioscience Corporation
07/21/20217:27AMInvestorsHub NewsWireLexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3NASDAQ:LEXXWLexaria Bioscience Corporation
07/15/20218:14AMInvestorsHub NewsWireLexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research CouncilNASDAQ:LEXXWLexaria Bioscience Corporation
06/03/20218:05AMInvestorsHub NewsWireLexaria's DehydraTECH(TM)-Enabled Remdesivir and Ebastine Effectively Inhibit the COVID-19 SARS-CoV-2 VirusNASDAQ:LEXXWLexaria Bioscience Corporation
05/20/20217:16AMInvestorsHub NewsWireLexaria's Newest DehydraTECHTM 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption..contNASDAQ:LEXXWLexaria Bioscience Corporation
05/12/20217:18AMInvestorsHub NewsWireLexaria Strengthens its International Patent Portfolio to 19 Patents GrantedNASDAQ:LEXXWLexaria Bioscience Corporation
05/06/20217:35AMInvestorsHub NewsWireLexaria Issues Successful Results from First 2021 Study, HYPER-A21-1NASDAQ:LEXXWLexaria Bioscience Corporation
04/14/20217:37AMInvestorsHub NewsWireLexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope NetworkNASDAQ:LEXXWLexaria Bioscience Corporation
04/06/20217:16AMInvestorsHub NewsWireLexaria to Evaluate DehydraTECHTM in Multiple New MarketsNASDAQ:LEXXWLexaria Bioscience Corporation
03/24/20218:00AMInvestorsHub NewsWireLexaria Technology Generates Positive Stability Testing for World-Class Ready to Drink CBD BeveragesNASDAQ:LEXXWLexaria Bioscience Corporation
03/16/20217:39AMInvestorsHub NewsWireLexaria's Antiviral Drug Evaluation Program ProgressingNASDAQ:LEXXWLexaria Bioscience Corporation
03/15/20218:30AMInvestorsHub NewsWireRapid Progress in Hypertension Studies by LexariaNASDAQ:LEXXWLexaria Bioscience Corporation
 Showing the most relevant articles for your search:NASDAQ:LEXXW